Exor Ventures

Type

CVC

Status

Active

Location

Amsterdam, Netherlands

Total investments

18

Average round size

19M

Portfolio companies

17

Rounds per year

3.00

Lead investments

3

Follow on index

0.06

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyArtificial IntelligenceMachine LearningManufacturingPharmaceuticalTherapeuticsClinical Trials

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistAI/Big DataB2B/EnterpriseCloud/InfrastructureConsumer/Retail Show 6 more
Stage focus
Series ASeries B
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
18
Lead investments
3
Rounds per year
3.00
Follow on index
0.06
Investments by industry
  • Software (5)
  • Therapeutics (3)
  • Machine Learning (3)
  • Pharmaceutical (2)
  • Clinical Trials (2)
  • Show 40 more
Investments by region
  • United States (8)
  • Israel (2)
  • France (2)
  • United Kingdom (2)
  • Italy (2)
  • Show 1 more
Peak activity year
2024

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
3
Avg. valuation at time of investment
23M
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Matter Neuroscience 27 Feb 2024 Seed 26M
ZELIQ 11 Jun 2024 Sales Automation Seed 10M Ile-de-France, Paris, France
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.